# Illustris Pharmaceuticals Inc. — Form D

Illustris Pharmaceuticals Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-03. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-03-03
- Form: D
- Accession: 0001140361-17-010503
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 14
- Date of first sale: 2016-12-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281774

## Issuer

- Name: Illustris Pharmaceuticals Inc.
- CIK: 0001697743
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 4030 Fabian Way, Suite B, PALO ALTO, CA, 94303
- Phone: 650-334-2095

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Andrew Khim Hirschberg | Director | Palo Alto, CA |
| Mark Prygocki | Director | Palo Alto, CA |
| Jonah Khim Shacknai | Director | Palo Alto, CA |
| Siak Khim Tan | Director | Irvine, CA |
| Jacob M Waugh | Director | Palo Alto, CA |
| Jaehoon M Lee | Executive Officer | Palo Alto, CA |
| Mark Prygocki | Executive Officer | Palo Alto, CA |
| Gloria M Vasquez | Executive Officer | Palo Alto, CA |
| Jacob M Waugh | Executive Officer | Palo Alto, CA |

## More

- [CIK 1697743 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1697743&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-17-010503.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.